Jan Gerstoft, MD

Professor
University of Copenhagen
Copenhagen, Hovedstaden, Denmark

Gilead Sciences, Inc (Other Financial or Material Support, Study Investigator (payment to employer))

Presentation(s):

• LB1 - Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

  Thursday, September 30, 2021
  5:15 PM - 5:30 PM EDT